CC

Charith Chandu

Director Director DIN 09112060
DIN 09112060 First appointment Mar 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Charith Chandu

Data last updated:

Charith Chandu was a Director at Serotonin Impex Private Limited (2021–2024) and Director at Serotonin Jems Private Limited (from 2021). The companies operate in Trading.

DIN 09112060
Primary Designation Director
Industry Trading
First Appointment 18 Mar 2021
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Serotonin Impex Private Limited U51909KA2021PTC147111
Director04 May 20212021₹62.5 Lakh (FY 2024)Active
Serotonin Jems Private Limited U36996KA2021PTC145508
Director18 Mar 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Serotonin Jems Private Limited
Serotonin Impex Private Limited
Premium access

Shareholding and investment profile for Charith Chandu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charith Chandu

Charith Chandu was first appointed on 18 Mar 2021 as Director at Serotonin Jems Private Limited.

Charith Chandu held 2 earlier board appointments: Serotonin Impex Private Limited (Director, 04 May 2021 to 11 Nov 2024); Serotonin Jems Private Limited (Director, from 18 Mar 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available